Bhavesh is a visionary scientist with more than 20 years of experience in Drug Discovery and Molecular Diagnostics. He has completed his PhD in Oncology from Frei University, Germany and Post Doctorate in Immuno-Oncology from Karolinska Institute, Sweden. Over the past two decades, he has worked in several Pharma & Biotech organizations in Asia, Europe and UK (Sun Pharma, Lupin, Aurigene Discovery Technology (Dr. Reddy’s), Nicholas Piramal, Charite Medicine University, De Montfort University and Wockhardt), and successfully contributed to R&D, Clinical Translation and Commercialization of Small Molecule and Biologics drugs. During this tenure, he has significantly contributed in Cancer, Autoimmune and Neurodegenerative disease research and Biomarker discovery, with cutting edge technologies in Genomics and Proteomics such as RT-PCR, NGS, Cytogenetics, CRISPR, CAR T-Cells and Artificial Intelligence. He has supervised PhD students and published several research articles in peer reviewed international journals. He enjoys scientific discussions, interacting and helping people.

The unprecedented crisis of the Covid-19 pandemic influenced and inspired Bhavesh to change his journey from corporate leadership to entrepreneurship. He founded Biomarkers Healthcare in June 2021 with a mission to contribute to solving problems in healthcare and medical diagnostics. Bhavesh firmly believes Molecular Research-driven solutions and innovative technological platforms are key transforming steps for Precise Diagnosis and Personalized & Precision Medicines across all the fields of disease, a way forward for result-oriented, best patient management in the 21st century. At Biomarkers Healthcare, Bhavesh provides overall leadership and strategic directions for the company’s growth, partnership and collaborations.